|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 9 of 167 found articles
| Title: |
Ansell SM, Bröckelmann PJ, von Keudell G, et al. Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from the pivotal phase 2 CheckMate 205 study. Blood Adv. 2023;7(20):6266-6274. |
| Author: | |
| Appeared in: |
Blood advances |
| Paging: | Volume 8 () nr. 4 pages 829-831 |
| Year: |
2024 |
| Contents: | |
| Publisher: |
The American Society of Hematology |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 9 of 167 found articles
| << previous | next >> |